Research Articles
Research articles concerning NAFLD are extracted from PubMed. For each individual article, related therapeutic strategies, targets, drugs and associated diseases in NAFLDkb are presented with knowledge graphs.
stats1
stats2
stats3
stats4
Search for:
fibrosis10255 records.
| Article ID | PMID | Source | Title | Publish Year | |
|---|---|---|---|---|---|
| A44698 | 27698966 | Middle East J Dig Dis | New Concepts on Pathogenesis and Diagnosis of Liver Fibrosis; A Review Article. | 2016 | Details |
| A44701 | 27683821 | J Infect Dis | Direct-Acting Antiviral-Induced Hepatitis C Virus Clearance Does Not Completely Restore the Altered Cytokine and Chemokine Milieu in Patients With Chronic Hepatitis C. | 2016 | Details |
| A44702 | 27679730 | J Ultrason | Is a fatty pancreas a banal lesion? | 2016 | Details |
| A44713 | 27625607 | Front Pharmacol | Exercise-Induced Release of Pharmacologically Active Substances and Their Relevance for Therapy of Hepatic Injury. | 2016 | Details |
| A44726 | 27534992 | J Lipid Res | Cholesterol 7α-hydroxylase protects the liver from inflammation and fibrosis by maintaining cholesterol homeostasis. | 2016 | Details |
| A44732 | 27499712 | Gastroenterol Hepatol (N Y) | Metabolic Manifestations and Complications Associated With Chronic Hepatitis C Virus Infection. | 2016 | Details |
| A44739 | 27484243 | Food Chem Toxicol | Hepatoprotection and hepatotoxicity of Heshouwu, a Chinese medicinal herb: Context of the paradoxical effect. | 2016 | Details |
| A44760 | 27401791 | J Hepatol | How to diagnose NAFLD in 2016. | 2016 | Details |
| A44778 | 27339672 | Crit Care Clin | Acute-on-chronic and Decompensated Chronic Liver Failure: Definitions, Epidemiology, and Prognostication. | 2016 | Details |
| A44779 | 27334756 | Mol Cell Biochem | Annexin A6 protein is downregulated in human hepatocellular carcinoma. | 2016 | Details |
| A44820 | 27183465 | Nucl Med Biol | Efficient radiosynthesis and non-clinical safety tests of the TSPO radioprobe [(18)F]FEDAC: Prerequisites for clinical application. | 2016 | Details |
| A44844 | 27097220 | PLoS One | Spaceflight Activates Lipotoxic Pathways in Mouse Liver. | 2016 | Details |
| A44863 | 27038645 | J Hepatol | PNPLA3 gene in liver diseases. | 2016 | Details |
| A44869 | 27018125 | Am J Gastroenterol | Erratum: Cost-Effective Evaluation of Nonalcoholic Fatty Liver Disease With NAFLD Fibrosis Score and Vibration-Controlled Transient Elastography. | 2016 | Details |
| A44873 | 27013235 | Genes Dev | The LATS2 tumor suppressor inhibits SREBP and suppresses hepatic cholesterol accumulation. | 2016 | Details |
| A44886 | 26960172 | J Pediatr Gastroenterol Nutr | Noninvasive Assessment of Nonalcoholic Steatohepatitis and Nonalcoholic Steatohepatitis-Related Fibrosis: Is There a Role for Cytokeratin 18? | 2016 | Details |
| A44891 | 26950044 | J Dig Dis | Consensus on the diagnosis and treatment of cholestatic liver diseases (2015, China). | 2016 | Details |
| A44893 | 26941826 | Evid Based Complement Alternat Med | Preclinical Models for Investigation of Herbal Medicines in Liver Diseases: Update and Perspective. | 2016 | Details |
| A44900 | 26914713 | Cancer | Metformin prevents hepatocellular carcinoma development by suppressing hepatic progenitor cell activation in a rat model of cirrhosis. | 2016 | Details |
| A44912 | 26847353 | J Gastrointest Surg | Hepatectomy After Yttrium-90 (Y90) Radioembolization-Induced Liver Fibrosis. | 2016 | Details |
| A44916 | 26820053 | Gastroenterology | Magnetic Resonance Imaging/Elastography Is Superior to Transient Elastography for Detection of Liver Fibrosis and Fat in Nonalcoholic Fatty Liver Disease. | 2016 | Details |
| A44924 | 26782133 | Hosp Pract (1995) | The Burden of Rehospitalization for Patients With Liver Cirrhosis. | 2016 | Details |
| A44926 | 26775630 | Gastroenterology | How Safe Is Moderate Alcohol Consumption in Overweight and Obese Individuals? | 2016 | Details |
| A44930 | 26738480 | Annu Rev Pharmacol Toxicol | Nuclear Receptors as Therapeutic Targets in Liver Disease: Are We There Yet? | 2016 | Details |
| A44931 | 26730276 | World J Hepatol | Extragastric manifestations of Helicobacter pylori infection: Possible role of bacterium in liver and pancreas diseases. | 2015 | Details |
| A44933 | 26707308 | Transplant Proc | Hepatic Steatosis as a Predictive Factor of Antiviral Effect of Pegylated Interferon Therapy in Patients With Hepatitis B. | 2015 | Details |
| A44936 | 26699087 | Hepatology | Histidine-rich glycoprotein promotes macrophage activation and inflammation in chronic liver disease. | 2016 | Details |
| A44940 | 26664664 | Ont Health Technol Assess Ser | Transient Elastography for Assessment of Liver Fibrosis and Steatosis: An Evidence-Based Analysis. | 2015 | Details |
| A44941 | 26664429 | J Res Med Sci | Resveratrol and liver: A systematic review. | 2015 | Details |
| A44948 | 26638936 | Aliment Pharmacol Ther | Letter: factors determining liver fibrosis - more to come. | 2016 | Details |
| A44952 | 26632699 | Medicine (Baltimore) | Significant Association Between Adiponutrin and Hepatocellular Carcinoma Risk. | 2015 | Details |
| A44976 | 26566061 | Eur J Gastroenterol Hepatol | Relationship of hepatic fibrosis, cirrhosis, and mortality with cholecystectomy in patients with hepatitis C virus infection. | 2016 | Details |
| A44977 | 26564715 | Am J Physiol Gastrointest Liver Physiol | Glial cell line-derived neurotrophic factor protects against high-fat diet-induced hepatic steatosis by suppressing hepatic PPAR-γ expression. | 2015 | Details |
| A44979 | 26544701 | AIDS | Transient elastography for the detection of hepatic fibrosis in HIV-monoinfected adults with elevated aminotransferases on antiretroviral therapy. | 2015 | Details |
| A44990 | 26513521 | Eur J Gastroenterol Hepatol | Neutrophil-to-lymphocyte ratio for predicting fibrosis in nonalcoholic fatty liver disease. | 2015 | Details |
| A45006 | 26448455 | Clin Transl Gastroenterol | Circulating Soluble CD163 is Associated with Steatohepatitis and Advanced Fibrosis in Nonalcoholic Fatty Liver Disease. | 2015 | Details |
| A45008 | 26447962 | J Clin Gastroenterol | Probiotics in Pediatric Liver Disease. | 2016 | Details |
| A45009 | 26447928 | Hepatology | Noninvasive predictors of fibrosis in NASH with and without cirrhosis, just as good as histology (and hepatic venous pressure gradient?). | 2015 | Details |
| A45016 | 26435214 | Toxicol Appl Pharmacol | Silent information regulator 1 (SIRT1) ameliorates liver fibrosis via promoting activated stellate cell apoptosis and reversion. | 2015 | Details |
| A45023 | 26409177 | Gastroenterology | Liver histology and clinical trials for nonalcoholic steatohepatitis-perspectives from 2 pathologists. | 2015 | Details |
| A45032 | 26378385 | Clin Transl Gastroenterol | Isoprene in the Exhaled Breath is a Novel Biomarker for Advanced Fibrosis in Patients with Chronic Liver Disease: A Pilot Study. | 2015 | Details |
| A45054 | 26278560 | Aliment Pharmacol Ther | Editorial: novel association between serum Pentraxin-2 levels and advanced fibrosis in well-characterised patients with non-alcoholic fatty liver disease--authors' reply. | 2015 | Details |
| A45055 | 26278559 | Aliment Pharmacol Ther | Editorial: novel association between serum Pentraxin-2 levels and advanced fibrosis in well-characterised patients with non-alcoholic fatty liver disease. | 2015 | Details |
| A45076 | 26167064 | World J Gastroenterol | Liver disease in menopause. | 2015 | Details |
| A45077 | 26162026 | Radiology | Hepatic MR Elastography: Clinical Performance in a Series of 1377 Consecutive Examinations. | 2015 | Details |
| A45082 | 26138651 | Dig Dis Sci | Concurrent Obesity, Diabetes, and Steatosis Increase Risk of Advanced Fibrosis Among HCV Patients: A Systematic Review. | 2015 | Details |
| A45130 | 25989922 | Hepatology | Is liver stiffness measurement to stage fibrosis in patients with nonalcoholic fatty liver disease ready for clinical use? | 2015 | Details |
| A45133 | 25986529 | Dig Dis Sci | Patatin-Like Phospholipase Domain-Containing 3 I148M Variant Is Associated with Liver Steatosis and Fat Distribution in Chronic Hepatitis B. | 2015 | Details |
| A45134 | 25974900 | Semin Liver Dis | Liver fibrosis in alcoholic liver disease. | 2015 | Details |
| A45140 | 25939859 | Liver Int | Serum cytokeratin-18 fragment levels predict development of type 2 diabetes mellitus in adult patients with NAFLD. | 2015 | Details |
| A45146 | 25919655 | Eur J Gastroenterol Hepatol | Is ultrasonography-diagnosed nonalcoholic fatty liver disease fibrosis score associated with the Framingham risk score? | 2015 | Details |
| A45159 | 25863525 | J Hepatol | Exercise and improvement of NAFLD: Practical recommendations. | 2015 | Details |
| A45161 | 25852814 | J Clin Aesthet Dermatol | Nonalcoholic Fatty liver disease and psoriasis: what a dermatologist needs to know. | 2015 | Details |
| A45164 | 25850345 | Curr Opin Gastroenterol | Advances in hepatology: 2015. | 2015 | Details |
| A45172 | 25820484 | Hepatology | Transmembrane 6 superfamily member 2 gene E167K variant impacts on steatosis and liver damage in chronic hepatitis C patients. | 2015 | Details |
| A45175 | 25809239 | Liver Int | Value of fetuin-A as a predictor of liver fibrosis in patients with nonalcoholic fatty liver disease. Author's reply. | 2015 | Details |
| A45184 | 25788206 | Hepatol Int | Two are better than one: noninvasive assessment of liver fibrosis in nonalcoholic fatty liver disease. | 2015 | Details |
| A45185 | 25782472 | Liver Int | Value of fetuin-A as a predictor of liver fibrosis in patients with nonalcoholic fatty liver disease. | 2015 | Details |
| A45222 | 25619318 | Liver Int | Non-invasive evaluation of liver fibrosis: More well-validated tests available for patient management. | 2015 | Details |
| A45223 | 25618312 | Dig Dis Sci | Reversing Advanced Hepatic Fibrosis in NASH: Clearly Possible, but Widely at Hand? | 2015 | Details |
| A45224 | 25617498 | J Hepatol | Non-alcoholic fatty liver disease: severity of fibrosis and its relationships with clinical and biological variables. | 2015 | Details |
| A45239 | 25564771 | Hepatology | Nonalcoholic fatty liver disease: Fibrosis portends a worse prognosis. | 2015 | Details |
| A45251 | 25547844 | Expert Opin Investig Drugs | Early to Phase II drugs currently under investigation for the treatment of liver fibrosis. | 2014 | Details |
| A45252 | 25546414 | Hepatology | Biochemical markers, liver biopsy, or magnetic resonance elastography to detect or exclude advanced fibrosis in patients with nonalcoholic fatty liver disease. | 2015 | Details |
| A45254 | 25543233 | J Gastroenterol | Effect of PNPLA3 rs738409 variant (I148 M) on hepatic steatosis, necroinflammation, and fibrosis in Japanese patients with chronic hepatitis C. | 2014 | Details |
| A45257 | 25502834 | Hepatology | TM6SF2 as a genetic risk factor for fibrosis. | 2015 | Details |
| A45260 | 25501544 | Am J Physiol Gastrointest Liver Physiol | A high-fat diet modulates iron metabolism but does not promote liver fibrosis in hemochromatotic Hjv⁻/⁻ mice. | 2014 | Details |
| A45266 | 25478921 | Clin Gastroenterol Hepatol | Nonalcoholic fatty liver disease and fibrosis progression: the good, the bad, and the unknown. | 2014 | Details |
| A45274 | 25454303 | Clin Liver Dis | Liver disease in the adolescent. | 2014 | Details |
| A45280 | 25418405 | World Rev Nutr Diet | Liver diseases. | 2014 | Details |
| A45290 | 25371482 | Gastroenterol Rep (Oxf) | Commentary on "Simple non-invasive biomarkers of advanced fibrosis in the evaluation of non-alcoholic fatty liver disease". | 2014 | Details |
| A45291 | 25371481 | Gastroenterol Rep (Oxf) | Is aspartate aminotransferase-to-platelet ratio index a biomarker in the evaluation of advanced fibrosis in non-alcoholic fatty liver disease? | 2014 | Details |
| A45307 | 25253983 | World J Gastroenterol | Is increased red cell distribution width an indicating marker of nonalcoholic steatohepatitis and fibrotic stage? | 2014 | Details |
| A45319 | 25199052 | Lab Invest | Western diet in ApoE-LDLR double-deficient mouse model of atherosclerosis leads to hepatic steatosis, fibrosis, and tumorigenesis. | 2014 | Details |
| A45323 | 25192564 | Gut | Vitamin D and liver fibrosis: let's start soon before it's too late. | 2014 | Details |
| A45325 | 25177166 | Korean J Physiol Pharmacol | Exendin-4 Improves Nonalcoholic Fatty Liver Disease by Regulating Glucose Transporter 4 Expression in ob/ob Mice. | 2014 | Details |
| A45332 | 25139186 | Digestion | Identifying soluble mediators of nuclear receptor and insulin signaling may enhance noninvasive diagnosis of fibrosis in Fatty liver disease. | 2014 | Details |
| A45346 | 25102955 | Liver Int | Interfering parameters in nonalcoholic fatty liver disease fibrosis score. | 2014 | Details |
| A45379 | 24909907 | Clin Gastroenterol Hepatol | FibroScan (vibration-controlled transient elastography): where does it stand in the United States practice. | 2014 | Details |
| A45399 | 24797484 | Clin Biochem | Uric acid levels decrease with fibrosis progression in patients with nonalcoholic fatty liver disease. | 2014 | Details |
| A45421 | 24699009 | Cell Cycle | CDKN1A: a double-edged sword in fatty liver? | 2014 | Details |
| A45429 | 24672667 | Gut Liver | Comments to prediction of advanced fibrosis in nonalcoholic fatty liver disease: an enhanced model of BARD score. | 2014 | Details |
| A45438 | 24585422 | Hepatology | The influence of menopause on the development of hepatic fibrosis in nonobese women with nonalcoholic fatty liver disease. | 2014 | Details |
| A45511 | 24222096 | Semin Liver Dis | Steatohepatitis secondary to long-term glucocorticoid treatment for congenital adrenal hyperplasia: a potential diagnostic pitfall. | 2013 | Details |
| A45523 | 24165222 | Nurs Res | Using transient elastography to detect chronic liver diseases in a primary care nurse consultancy. | 2014 | Details |
| A45526 | 24133662 | Clin Mol Hepatol | Chasing after novel non-invasive markers to identify advanced fibrosis in NAFLD. | 2013 | Details |
| A45528 | 24129500 | Eur J Nutr | Adiponectin receptor 1 enhances fatty acid metabolism and cell survival in palmitate-treated HepG2 cells through the PI3 K/AKT pathway. | 2013 | Details |
| A45549 | 23973850 | Gastroenterology | NAFLD fibrosis score: is it ready for wider use in clinical practice and for clinical trials? | 2013 | Details |
| A45564 | 23871243 | Curr Biol | Cell-to-cell heterogeneity in lipid droplets suggests a mechanism to reduce lipotoxicity. | 2013 | Details |
| A45572 | 23837135 | Clin Mol Hepatol | Noninvasive markers: a double-edged sword that stratifies nonalcoholic steatohepatitis. | 2013 | Details |
| A45575 | 23813872 | Hepatology | High-fat and high-sucrose (western) diet induces steatohepatitis that is dependent on fructokinase. | 2013 | Details |
| A45582 | 23787705 | Hepatology | Nuclear control of inflammation and fibrosis in nonalcoholic steatohepatitis: therapeutic potential of dual peroxisome proliferator-activated receptor alpha/delta agonism. | 2013 | Details |
| A45595 | 26201792 | Hepatol Int | The Fatty Liver Index has limited utility for the detection and quantification of hepatic steatosis in obese patients. | 2012 | Details |
| A45597 | 23720735 | J Biol Chem | C/EBP homologous protein-induced macrophage apoptosis protects mice from steatohepatitis. | 2013 | Details |
| A45602 | 23710178 | Int J Endocrinol | Major Histocompatibility Class II Pathway Is Not Required for the Development of Nonalcoholic Fatty Liver Disease in Mice. | 2013 | Details |
| A45607 | 23698242 | Med Sci Sports Exerc | Exercise reduces inflammation and oxidative stress in obesity-related liver diseases. | 2013 | Details |
| A45609 | 23686813 | Hepatology | Adipose tissue-derived stem cells as a regenerative therapy for a mouse steatohepatitis-induced cirrhosis model. | 2013 | Details |
| A45628 | 23566931 | Clin Chim Acta | Upper limit of normal for alanine aminotransferase: quo vadis? | 2013 | Details |
| A45631 | 26366024 | Appl Radiol | MR Elastography of Liver Disease: State of the Art. | 2013 | Details |
| A45645 | 23482364 | Georgian Med News | [Role of proapoptotic p-53 factor in pathogenesis of nonalcoholic hepatosteatosis]. | 2013 | Details |